Published in N Engl J Med on September 03, 1992
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
Taenia solium cysticercosis. Lancet (2003) 5.89
Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol (2011) 2.20
Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis (1999) 1.63
Evaluation of enzyme-linked immunoassay for serological diagnosis of cysticercosis. J Clin Microbiol (1995) 1.61
Isolation and characterization of species-specific DNA probes from Taenia solium and Taenia saginata and their use in an egg detection assay. J Clin Microbiol (1995) 1.56
Deaths from cysticercosis, United States. Emerg Infect Dis (2007) 1.49
Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries. J Neurol Sci (2012) 1.42
A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41
Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru. J Infect Dis (1997) 1.38
Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry (1997) 1.34
Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis (2011) 1.31
Neurocysticercosis in Oregon, 1995-2000. Emerg Infect Dis (2004) 1.28
Sympatric occurrence of Taenia solium, T. saginata, and T. asiatica, Thailand. Emerg Infect Dis (2007) 1.25
Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011. PLoS One (2013) 1.16
Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol (2010) 1.15
Molecular characterization and diagnostic value of Taenia solium low-molecular-weight antigen genes. J Clin Microbiol (2000) 1.13
Controversies in the management of cysticercosis. Emerg Infect Dis (1997) 1.07
Prevalence and risk factors associated with human Taenia solium infections in Mbozi District, Mbeya Region, Tanzania. PLoS Negl Trop Dis (2013) 1.06
Specific Taenia crassiceps and Taenia solium antigenic peptides for neurocysticercosis immunodiagnosis using serum samples. J Clin Microbiol (2000) 1.03
Seroprevalence of antibodies against Taenia solium cysticerci among refugees resettled in United States. Emerg Infect Dis (2012) 1.03
Tapeworm infection--the long and the short of it. N Engl J Med (1992) 1.01
Neglected parasitic infections in the United States: cysticercosis. Am J Trop Med Hyg (2014) 1.01
Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa. Parasit Vectors (2015) 1.00
Taenia solium Human Cysticercosis: A Systematic Review of Sero-epidemiological Data from Endemic Zones around the World. PLoS Negl Trop Dis (2015) 1.00
Taeniasis and cysticercosis due to Taenia solium in Japan. Parasit Vectors (2012) 0.99
Neurocysticercosis in the United States. Pathog Glob Health (2012) 0.98
Cysticercosis-related deaths, California. Emerg Infect Dis (2004) 0.95
Taenia solium Tapeworm Infection, Oregon, 2006-2009. Emerg Infect Dis (2011) 0.95
Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr (2009) 0.93
Solitary neurocysticercosis case caused by Asian genotype of Taenia solium confirmed by mitochondrial DNA analysis. J Clin Microbiol (2004) 0.91
Neurologic parasitic infections in immigrants and travelers. Semin Neurol (2011) 0.87
Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect Immun (1998) 0.86
Evaluation of recombinant HP6-Tsag, an 18 kDa Taenia saginata oncospheral adhesion protein, for the diagnosis of cysticercosis. Parasitol Res (2007) 0.86
Prevalence case-control study of epilepsy in three Burkina Faso villages. Acta Neurol Scand (2012) 0.86
Cysticercosis-related hospitalizations in the United States, 1998-2011. Am J Trop Med Hyg (2014) 0.84
Prevalence of Neurocysticercosis in People with Epilepsy in the Eastern Province of Zambia. PLoS Negl Trop Dis (2015) 0.84
Progesterone induces mucosal immunity in a rodent model of human taeniosis by Taenia solium. Int J Biol Sci (2011) 0.81
State of the art of Taenia solium as compared to Taenia asiatica. Korean J Parasitol (2013) 0.80
Progesterone induces scolex evagination of the human parasite Taenia solium: evolutionary implications to the host-parasite relationship. J Biomed Biotechnol (2009) 0.79
The present situation and towards the prevention and control of neurocysticercosis on the tropical island, Bali, Indonesia. Parasit Vectors (2015) 0.79
Managing neurocysticercosis: challenges and solutions. Int J Gen Med (2015) 0.79
Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy. J Immunol (2010) 0.78
Study and ranking of determinants of Taenia solium infections by classification tree models. Am J Trop Med Hyg (2014) 0.78
Cysticercosis. Curr Treat Options Neurol (2000) 0.77
The hamster model for identification of specific antigens of Taenia solium tapeworms. J Biomed Biotechnol (2011) 0.77
Seizure in people with newly diagnosed active or transitional neurocysticercosis. Seizure (2010) 0.77
Serodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerci. Clin Diagn Lab Immunol (2001) 0.77
Simple Identification of Human Taenia Species by Multiplex Loop-Mediated Isothermal Amplification in Combination with Dot Enzyme-Linked Immunosorbent Assay. Am J Trop Med Hyg (2016) 0.75
Commentary. J Neurosci Rural Pract (2013) 0.75
In Response. Am J Trop Med Hyg (2015) 0.75
Preventing neurocysticercosis. BMJ (1993) 0.75
Cysticercosis with an Orbital Tropism in Twins. Am J Trop Med Hyg (2015) 0.75
Third-ventricular neurocysticercosis: hydraulic maneuvers facilitating endoscopic resection. Childs Nerv Syst (2013) 0.75
Modelling the risk of Taenia solium exposure from pork produced in western Kenya. PLoS Negl Trop Dis (2017) 0.75
A new parasiticidal compound in T. solium cysticercosis. Biomed Res Int (2012) 0.75
The highly antigenic 53/25 kDa Taenia solium protein fraction with cathepsin-L like activity is present in the oncosphere/cysticercus and induces non-protective IgG antibodies in pigs. Vet Immunol Immunopathol (2011) 0.75
Immune destruction of larval taenia crassiceps in mice. Infect Immun (2000) 0.75
Mapping occurrence of Taenia solium taeniosis/cysticercosis and areas at risk of porcine cysticercosis in Central America and the Caribbean basin. Parasit Vectors (2017) 0.75
Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol (1984) 14.64
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
A strategy to reveal high-frequency RFLPs along the human X chromosome. Am J Hum Genet (1984) 7.73
Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob Agents Chemother (1986) 7.71
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science (1992) 7.44
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell (1999) 5.01
The initiation sites for RNA transcription in Ad2 DNA. Cell (1977) 4.76
Tetrodes markedly improve the reliability and yield of multiple single-unit isolation from multi-unit recordings in cat striate cortex. J Neurosci Methods (1995) 4.60
Attachment of Mycoplasma pneumoniae to respiratory epithelium. Infect Immun (1976) 4.35
Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol (2001) 4.12
T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature (1987) 3.96
Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr (1981) 3.72
Hypertension treated by salt restriction. Lancet (1978) 3.59
Trajectory encoding in the hippocampus and entorhinal cortex. Neuron (2000) 3.48
Conversion of a homogeneously methicillin-resistant strain of Staphylococcus aureus to heterogeneous resistance by Tn551-mediated insertional inactivation. Eur J Clin Microbiol (1986) 3.44
HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA (2001) 3.41
Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin. J Clin Invest (1985) 3.35
A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N Engl J Med (1991) 2.80
Oxolinic acid metabolism by man. Arch Int Pharmacodyn Ther (1968) 2.60
The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns (1999) 2.58
Oral contraceptives and fatal pulmonary embolism. Lancet (2000) 2.57
Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev (1996) 2.55
Global transcriptional response of Bacillus subtilis to heat shock. J Bacteriol (2001) 2.49
Lemierre's syndrome: more than a historical curiosa. Postgrad Med J (2004) 2.46
Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun (1996) 2.44
The use of thick-smear antigen slides in the malaria indirect fluorescent antibody test. J Parasitol (1967) 2.40
Oxidative injury and inflammatory periodontal diseases: the challenge of anti-oxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med (1999) 2.33
Antimicrobial resistance: Antibiotics and consultant oral microbiologist posts. Br Dent J (2016) 2.32
Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut (1999) 2.28
Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis (1994) 2.24
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24
Update on spinal epidural abscess: 35 cases and review of the literature. Rev Infect Dis (1987) 2.20
THE RELATION OF THE TUNNICLIFF AND FERRY DIPLOCOCCI TO MEASLES. Am J Public Health (N Y) (1927) 2.19
Validity of the term "family doctor": a limited study in Hamilton, Ontario. Can Med Assoc J (1968) 2.19
Behaviour of the rod network in the tiger salamander retina mediated by membrane properties of individual rods. J Physiol (1980) 2.15
A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ (2000) 2.11
Mutations, duplication, and deletion of recombined switch regions suggest a role for DNA replication in the immunoglobulin heavy-chain switch. Mol Cell Biol (1989) 2.10
Barbiturate abuse and addiction and their relationship to alcohol and alcoholism. Can Med Assoc J (1971) 2.10
Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans. Biol Mass Spectrom (1991) 2.10
Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect Immun (2000) 2.07
Diabetic foot ulcers. Nurs Stand (2002) 2.03
Organisational psychopaths and our health culture. Nurs N Z (2001) 2.02
Double-blind trial of steroid tapering in acute asthma. Lancet (1993) 2.01
Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J Exp Med (1988) 1.89
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85
Maternal adaptation to high-altitude pregnancy: an experiment of nature--a review. Placenta (2004) 1.85
The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased. Br J Clin Pharmacol (1976) 1.80
The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res (2001) 1.80
Potential eradicability of taeniasis and cysticercosis. Bull Pan Am Health Organ (1993) 1.78
Oligonucleotides in heterogeneous nuclear RNA: similarity of inverted repeats and RNA from repetitious DNA sites. Biochemistry (1978) 1.77
Estimates of costs of primary care physician turnover. Am J Manag Care (1999) 1.76
Measuring the ability to meet family needs in an intensive care unit. Crit Care Med (1998) 1.76
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol (1993) 1.76
Immunodiagnosis of taeniasis by coproantigen detection. Parasitology (1990) 1.75
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet (2009) 1.74
Babesiosis in Washington State: a new species of Babesia? Ann Intern Med (1993) 1.71
Production of monoclonal antibodies to Naegleria fowleri, agent of primary amebic meningoencephalitis. J Clin Microbiol (1987) 1.69
Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa. Int J Tuberc Lung Dis (2012) 1.64
Evolutionary social psychology and family homicide. Science (1988) 1.62
Pasteurella multocida infection; report in urban setting and review of spectrum of human disease. N Y State J Med (1980) 1.62
Indirect fluorescent-antibody tests for parasitic diseases. V. An evaluation of a thick-smear antigen in the IFA test for malaria antibodies. Am J Trop Med Hyg (1969) 1.61
Syndromic surveillance at hospital emergency departments--southeastern Virginia. MMWR Morb Mortal Wkly Rep (2004) 1.60
Congenital toxoplasmosis: a review. Obstet Gynecol Surv (2001) 1.60
Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. Am J Trop Med Hyg (1992) 1.59
Prevalence of tetracycline resistance genes in oral bacteria. Antimicrob Agents Chemother (2003) 1.59
Loss-of-function mutations in SIP1 Smad interacting protein 1 result in a syndromic Hirschsprung disease. Hum Mol Genet (2001) 1.58
Prevalence of lumbar disc degeneration observed by magnetic resonance in symptomless women. Lancet (1986) 1.57
Isolation and characterization of species-specific DNA probes from Taenia solium and Taenia saginata and their use in an egg detection assay. J Clin Microbiol (1995) 1.56
Infectious disease pathology. Clin Infect Dis (2001) 1.56
Variation in GABA mini amplitude is the consequence of variation in transmitter concentration. Neuron (1995) 1.53
Interpersonal influences in adolescent drug use--the role of older siblings, parents, and peers. Int J Addict (1986) 1.53
Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A. J Virol (2008) 1.52
Difficult arterial cannulation in children: is a near-infrared vascular imaging system the answer? Br J Anaesth (2012) 1.52
Signal clipping by the rod output synapse. Nature (1987) 1.50
Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and/or knee: a randomised trial. Osteoarthritis Cartilage (2011) 1.50
Effects of creatine supplementation on body composition, strength, and sprint performance. Med Sci Sports Exerc (1998) 1.49
Histological description of tomographic images of Taenia solium cysticerci in pig brains. Clin Imaging (1989) 1.49
First record in America of Aedes albopictus naturally infected with dengue virus during the 1995 outbreak at Reynosa, Mexico. Med Vet Entomol (1997) 1.48
A randomized controlled trial of early amniotomy. Br J Obstet Gynaecol (1991) 1.48
Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. Am J Trop Med Hyg (1997) 1.48
Age-related changes in the relative growth of the posterior fossa. J Child Neurol (1991) 1.48
The neuron-specific K-Cl cotransporter, KCC2. Antibody development and initial characterization of the protein. J Biol Chem (1999) 1.47
Transfer of a conjugative transposon, Tn5397 in a model oral biofilm. FEMS Microbiol Lett (1999) 1.47
Taenia solium taeniasis and cysticercosis in a Mexican village. Trop Med Parasitol (1988) 1.46
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am J Med (1988) 1.45
Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci U S A (1982) 1.44
Implementation of proficiency testing in conjunction with a rechecking system for external quality assurance in tuberculosis laboratories in Mexico. Int J Tuberc Lung Dis (2003) 1.44
Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut (1985) 1.43
Preventing congenital toxoplasmosis. MMWR Recomm Rep (2000) 1.43
Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain (1995) 1.42
The properties of single cones isolated from the tiger salamander retina. J Physiol (1982) 1.42
Successful treatment of fungal prosthetic valve endocarditis: case report and review. Clin Infect Dis (1996) 1.42
Schistosomiasis in Lake Malawi. Lancet (1996) 1.42
Primary care physician job satisfaction and turnover. Am J Manag Care (2001) 1.41
Immunoblot (western blot) and double diffusion (DD5) tests for hydatid disease cross-react with sera from patients with cysticercosis. Trans R Soc Trop Med Hyg (1992) 1.41
Audit of multiple insulin injection regimens in a large outpatient diabetic population. Diabetes Res Clin Pract (1992) 1.41
Convenient pocket insulin syringe. Lancet (1981) 1.40
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers. Vaccine (2006) 1.39